Insurance Company Strategic alliance with selected insurance coy to provide the benefit. Costumer Best campaign and well informed about the various treatment available to assist them in having child c.
One option was to keep real inflation- adjusted prices stable over time as this enhanced the legitimacy of the initial launch price. Medi-Cult worried that competitors would break Medi-Cults IVM Medi cult case patent by using molecular modeling also known as reverse engineering.
Competitor c. Svend Lindenberg, a physician at Herlev Hospital in Denmark, believed that patients would choose IVM because the process was very easy for the patient to comprehend and easy to participate in, and because there was no risk of hyper- stimulation from hormones.
Based on the Exhibit 4 : a. IVM is a revolutionary product of the Medi-Cult biotechnology company. The technology become an industrial standard IVF become IVM and Medi Cult can have a two or three years advantage by being the first to market since any company that wished to introduce a competing product or process would have to undertake the clinical trial and document live births.
There was no tradition for pricing media at this level, and everybody would know that the cost to produce the IVM medium was insignificant, when compared to the current price for medication. In contrast, the French authorities allowed four free attempts cycles per patient; beyond this, the patient had to pay for any additional treatments.
But now the company faced new challenges: regulatory constraints; larger competitors; introducing a new product into the local and global marketplace; and how much to charge for the new technology.
Reimbursement of infertility treatments by insurance companies and governments was low because infertility patients were not considered diseased.